Search





Search





PRESS DIGEST- New York Times business news - April 1

ReutersApr 1, 2026 5:43 AM

April 1 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

- Eli Lilly LLY.N reached a deal on Tuesday to buy Centessa Pharmaceuticals 260y.F, a company developing treatments for the sleep disorder narcolepsy and other neurological conditions, in a deal worth about $6.3 billion.

- McCormick & Company MKC.N said on Tuesday that it planned to combine with Unilever’s ULVR.L food business to form a new entity with some $20 billion in annual revenue.

- A federal judge ruled on Tuesday that U.S. President Donald Trump’s executive order barring the federal funding of NPR and PBS violated the First Amendment.

- The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Trump Withdrawal Intent Reshapes Liquidity, Bitcoin Breaks $68,000 Mark

As the U.S. and Iran signal potential ceasefire negotiations, Bitcoin surged past $68,000, with a continued short-term rally expected.

Micron Stock Gains 5% as Google’s TurboQuant Sparks 20% Valuation Gap, Eyeing Semiconductor Rally Revival

TradingKey - During the U.S. trading session on March 31, Micron staged a strong rebound, closing up 4.98%. This performance may boost investor confidence following the recent collective correction in memory stocks. Beyond Micron, the semiconductor sector saw broad gains: SanDisk (SNDK) closed up 10

Buffett Admits Selling Apple Early, Can Apple Stock Price Still Rise? Need to Watch These Three Signals

TradingKey — Warren Buffett admitted that trimming his stake in Apple was premature. This statement garnered market attention not only because gains have exceeded $100 billion, but more importantly, because it highlights a more practical issue: once a company becomes sufficiently successful and mass

What Is Palantir? Can Palantir’s Stock Price Return to $200 in 2026?

TradingKey - In today’s highly competitive technology landscape, Palantir (PLTR), as a company with a core focus on big data and artificial intelligence, has garnered widespread attention through its unique technological advantages and market positioning.

Bitcoin Price Analysis: What Is to Stop BTC from Making Another Run at All-Time Highs in 2026?

This strategic analysis covers institutional BTC price targets from JPMorgan and Fidelity, the impact of the U.S. Strategic Reserve, and whether the four-year cycle is broken. Stay updated on BTC to USD trends and key market risks.

Tradingkey

KeyAI

